TY - JOUR
T1 - D2/D3 Dopamine Receptor Heterodimers Exhibit Unique Functional Properties
AU - Scarselli, Marco
AU - Novi, Francesca
AU - Schallmach, Ester
AU - Lin, Ridwan
AU - Baragli, Alessandra
AU - Colzi, Anna
AU - Griffon, Nathalie
AU - Corsini, Giovanni U.
AU - Sokoloff, Pierre
AU - Levenson, Robert
AU - Vogel, Zvi
AU - Maggio, Roberto
PY - 2001/8/10
Y1 - 2001/8/10
N2 - Evidence for heterodimerization has recently been provided for dopamine D1 and adenosine A1 receptors as well as for dopamine D2 and somatostatin SSTR5 receptors. In this paper, we have studied the possibility that D2 and D3 receptors interact functionally by forming receptor heterodimers. Initially, we split the two receptors at the level of the third cytoplasmic loop into two fragments. The first, containing transmembrane domains (TM) I to V and the N-terminal part of the third cytoplasmic loop, was named D2trunk or D 3trunk, and the second, containing the C-terminal part of the third cytoplasmic loop, TMVI and TMVII, and the C-terminal tail, was named D 2tail or D3tail. Then we defined the pharmacological profiles of the homologous (D2trunk/ D2tail and D 3trunk/D3tail) as well as of the heterologous (D 2trunk/D3tail and D3trunk/D2tail) cotransfected receptor fragments. The pharmacological profile of the cross-cotransfected fragments was different from that of the native D 2 or D3 receptors. In most cases, the D 3trunk/D2tail was the one with the highest affinity for most agonists and antagonists. Moreover, we observed that all of these receptor fragments reduced the expression of the wild type dopamine D2 and D3 receptors, suggesting that D2 and D3 receptors can form complexes with these fragments and that these complexes bind [3H]nemonapride less efficiently or are not correctly targeted to the membrane. In a second set of experiments, we tested the ability of the split and the wild type receptors to inhibit adenylyl cyclase (AC) types V and VI. All of the native and split receptors inhibited AC-V and AC-VI, with the exception of D3, which was unable to inhibit AC-VI. We therefore studied the ability of D2 and D3 to interact functionally with one another to inhibit AC-VI. We found that with D2 alone, R-(+)-7-hydroxydypropylaminotetralin hydrobromide inhibited AC-VI with an IC50 of 2.05 ± 0.15 nM, while in the presence of D 2 and D3 it inhibited AC-VI with an IC50 of 0.083 ± 0.011 nM. Similar results were obtained with a chimeric cyclase made from AC-V and AC-VI. Coimmunoprecipitation experiments indicate that D 2 and D3 receptors are capable of physical interaction.
AB - Evidence for heterodimerization has recently been provided for dopamine D1 and adenosine A1 receptors as well as for dopamine D2 and somatostatin SSTR5 receptors. In this paper, we have studied the possibility that D2 and D3 receptors interact functionally by forming receptor heterodimers. Initially, we split the two receptors at the level of the third cytoplasmic loop into two fragments. The first, containing transmembrane domains (TM) I to V and the N-terminal part of the third cytoplasmic loop, was named D2trunk or D 3trunk, and the second, containing the C-terminal part of the third cytoplasmic loop, TMVI and TMVII, and the C-terminal tail, was named D 2tail or D3tail. Then we defined the pharmacological profiles of the homologous (D2trunk/ D2tail and D 3trunk/D3tail) as well as of the heterologous (D 2trunk/D3tail and D3trunk/D2tail) cotransfected receptor fragments. The pharmacological profile of the cross-cotransfected fragments was different from that of the native D 2 or D3 receptors. In most cases, the D 3trunk/D2tail was the one with the highest affinity for most agonists and antagonists. Moreover, we observed that all of these receptor fragments reduced the expression of the wild type dopamine D2 and D3 receptors, suggesting that D2 and D3 receptors can form complexes with these fragments and that these complexes bind [3H]nemonapride less efficiently or are not correctly targeted to the membrane. In a second set of experiments, we tested the ability of the split and the wild type receptors to inhibit adenylyl cyclase (AC) types V and VI. All of the native and split receptors inhibited AC-V and AC-VI, with the exception of D3, which was unable to inhibit AC-VI. We therefore studied the ability of D2 and D3 to interact functionally with one another to inhibit AC-VI. We found that with D2 alone, R-(+)-7-hydroxydypropylaminotetralin hydrobromide inhibited AC-VI with an IC50 of 2.05 ± 0.15 nM, while in the presence of D 2 and D3 it inhibited AC-VI with an IC50 of 0.083 ± 0.011 nM. Similar results were obtained with a chimeric cyclase made from AC-V and AC-VI. Coimmunoprecipitation experiments indicate that D 2 and D3 receptors are capable of physical interaction.
UR - http://www.scopus.com/inward/record.url?scp=0035839599&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035839599&partnerID=8YFLogxK
U2 - 10.1074/jbc.M102297200
DO - 10.1074/jbc.M102297200
M3 - Article
C2 - 11373283
AN - SCOPUS:0035839599
SN - 0021-9258
VL - 276
SP - 30308
EP - 30314
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 32
ER -